Skip to main navigation

Investor Relations

Company Statements Media Contact Email Alerts

Events & Presentations Financials Stock Information Governance Resources

Patients Team Community Environment Compliance & Transparency

Our Locations Medical Information

magnifying glass icon

Main Nav

Our Company
What We Do
Culture & Careers
Patient Resources
HCP Resources
Our Stories
Responsibility

Our Company
What We Do
Culture & Careers
Patient Resources
HCP Resources
Our Stories
Responsibility

Main Nav

Our Company
What We Do
Culture & Careers
Patient Resources
HCP Resources
Our Stories
News
Investors
Responsibility
Contact Us
United States

Home > Investors > events > event details > Pemazyre FDA Approval

Incyte International Locations

NORTH AMERICA— HEADQUARTERS

EUROPE— HEADQUARTERS

THE NETHERLANDS

Close

Event Details

Events
Corporate Presentations
Scientific Presentations

Pemazyre FDA Approval

Apr 20, 2020 at 8:00 AM EDT

Investor Contacts

Ben Strain

Head of Investor Relations

© 2012-2024 Incyte.

Legal Notice
Suppliers
Site Map

Privacy Policy
Cookie Policy
Consumer Health Data Privacy Policy